Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Acupoint in Irritable Bowel Syndrome Based on Biological Characteristics: A Prospective Cohort Study

NCT06365801 is registered in ClinicalTrials.gov with The Third Affiliated hospital of Zhejiang Chinese Medical University as lead sponsor.

NCT NCT06365801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06365801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Acupoint in Irritable Bowel Syndrome Based on Biological Characteristics: A Prospective Cohort Study
Lead sponsor
The Third Affiliated hospital of Zhejiang Chinese Medical University
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2024
Completion date
December 31, 2025
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome